Post-approval studies (Phase 4)Study completedNCT03116828
What this trial is testing
A Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures
Who this might be right for
Epilepsy With Partial On-set Seizures
Sumitomo Pharma America, Inc. 102